Clinical Trial Update: Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485) [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the efficacy against tuberculosis, safety, and immunogenicity of the MVA85A/AERAS-485 vaccine in HIV-infected adults has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• MVA85A/AERAS-485 (MVA85A (AERAS-485) vaccine)

Snippet

Sponsor: Aeras | Conditions: Tuberculosis, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2015-08-26